Basic Tofranil Information

• INN (International Nonproprietary Name): Imipramine
• Brand Names Available In Australia: not specified
• ATC Code: N06AA02
• Forms & Dosages: Tablets 10 mg, 25 mg, 50 mg (imipramine hydrochloride); Capsules 75 mg, 100 mg, 125 mg, 150 mg (imipramine pamoate)
• Manufacturers In Australia: Novartis (originator, Tofranil) and multiple generic manufacturers; offered via local pharmaceutical distributors and pharmacy e‑commerce platforms
• Registration Status In Australia: not specified
• OTC / Rx Classification: Prescription Only (Rx)

Latest Research Highlights

Worried whether Tofranil still has a place in modern treatment?

Recent Australian and international studies between 2022 and 2024 reinforce imipramine’s niche role for treatment‑resistant depression and childhood nocturnal enuresis when behavioural steps alone fail.

Systematic reviews continue to show imipramine and other tricyclic antidepressants have similar antidepressant effect sizes to older TCAs such as amitriptyline and nortriptyline, but they carry higher anticholinergic and cardiotoxic risks compared with SSRIs.

Australian pharmacovigilance summaries to 2023 reported orthostatic hypotension, anticholinergic effects and cardiac conduction changes as the most common serious events in older adults on imipramine.

Small randomised trials and cohorts confirm standard doses of imipramine reach peak blood levels within about two to six hours, supporting once‑ or twice‑daily dosing for steady coverage.

For nocturnal enuresis, short‑term trials (one to three months) demonstrate benefit while the drug is used, but relapse frequently occurs after stopping, so intermittent or time‑limited courses are the pragmatic approach.

Clinicians continue to balance efficacy against safety signals when choosing imipramine over SSRIs or other agents.

Clinical Effectiveness In Australia

Are Australian doctors still prescribing Tofranil and does it work here?

PBS and clinic experience show imipramine remains effective for selected depressive presentations and for childhood nocturnal enuresis, but it is prescribed less often than SSRIs because of tolerability concerns.

TGA adverse‑event reporting highlights baseline ECGs and cautious dosing in older or cardiac‑risk patients when imipramine is used.

Therapeutic response for mood symptoms usually appears over two to four weeks, with full effect taking longer, while enuresis response can be seen quickly when a bedtime dose is used.

Australian psychiatrists commonly reserve imipramine for treatment‑resistant depression, severe psychomotor retardation profiles, or when neuropathic pain coexists and a tricyclic may offer dual benefit.

PBS listings vary by formulation and indication so price and subsidy affect dispensing; check the current PBS schedule before advising patients about out‑of‑pocket costs.

Indications And Expanded Uses

What is Tofranil actually approved for and when is it used off‑label?

Regulatory approvals internationally identify imipramine for major depressive disorder and childhood nocturnal enuresis as primary indications.

In practice, Australian clinicians also use imipramine off‑label for chronic neuropathic pain, migraine prophylaxis and some refractory anxiety or sleep disturbance cases where other medicines have failed.

Nocturnal enuresis dosing is low and time‑limited: common starting doses for children are 10–25 mg at bedtime with increases to age‑appropriate maxima (up to 50 mg for 6–12 years and 75 mg for older adolescents) if needed.

Off‑label prescribing requires informed consent and closer monitoring, including ECG checks when cardiac risk factors exist and counselling about common anticholinergic effects such as dry mouth and constipation.

Composition And Brand Landscape

Which imipramine products might you see on the shelf or online?

The active ingredient is imipramine, supplied as imipramine hydrochloride or imipramine pamoate in tablet and capsule forms.

Tofranil is the global originator brand and remains widely recognised, while many markets now supply imipramine mainly as generics from manufacturers such as Teva, Mylan and Sandoz.

Common tablet strengths internationally include 10 mg, 25 mg and 50 mg for the hydrochloride salt, and pamoate capsules are available at higher strengths (75 mg to 150 mg) in some markets.

ATC classification is N06AA02, placing imipramine among tricyclic antidepressants and non‑selective monoamine reuptake inhibitors.

Contraindications And Special Precautions

Who should never be given Tofranil and who needs extra care?

Absolute contraindications include known hypersensitivity to imipramine or other TCAs, recent myocardial infarction and concurrent monoamine oxidase inhibitor therapy.

Relative contraindications that call for careful consideration include significant cardiac disease, seizure disorders, narrow‑angle glaucoma, urinary retention or significant prostatic hypertrophy, and severe hepatic or renal impairment.

Start elderly patients on low doses (typically 10–25 mg daily) because they are more sensitive to orthostatic hypotension and anticholinergic effects.

Pregnant and breastfeeding patients should have a specialist review; consultation with obstetric psychiatry is recommended before starting imipramine.

Providers should offer culturally safe care and enhanced monitoring for Indigenous patients with higher cardiometabolic comorbidity, and counsel all patients to avoid alcohol and to be cautious with driving until their response to the medicine is known.

Dosage Guidelines

How is Tofranil usually dosed for different patients and conditions?

For adults with major depressive disorder a common starting regimen is 75 mg per day in divided doses, with gradual titration to 150–200 mg daily as tolerated and product information allowing up to 300 mg daily in severe cases.

Children treated for nocturnal enuresis generally start at 10–25 mg at bedtime, increasing up to 50 mg for ages 6–12 or up to 75 mg for older adolescents if needed.

Elderly people and patients with hepatic or renal impairment should start on low doses of 10–25 mg per day and be titrated slowly with close monitoring.

Pharmacokinetics support peak blood levels in two to six hours and a long half‑life, so once‑ or twice‑daily dosing is practical depending on tolerability and sleepiness.

Before starting, baseline checks should include an ECG for patients with cardiac risk, plus electrolytes and liver function where clinically indicated.

Interactions Overview

What medicines should never be mixed with Tofranil?

Major interaction risks include life‑threatening serotonin syndrome with concurrent SSRIs or MAOIs, and increased anticholinergic burden when combined with other antimuscarinic drugs.

Co‑prescribing QT‑prolonging medicines raises the risk of arrhythmia, so check the full medication list before dispensing imipramine.

Alcohol and other central nervous system depressants amplify sedation and orthostatic hypotension and should be avoided while treatment is being established.

Imipramine is metabolised through cytochrome P450 pathways so strong CYP inhibitors or inducers can alter plasma levels, raising toxicity risk or reducing effectiveness.

Pharmacist‑led medication reconciliation and targeted counselling are essential, especially for older Australians on multiple therapies where TGA reports have described adverse events linked to polypharmacy.

Cultural Perceptions And Patient Habits

Will patients accept a medicine described as an “older” antidepressant?

Many Australians see TCAs as older medicines and are cost‑sensitive, checking PBS status and favouring generics when available.

Pharmacists in community chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart are trusted sources of advice on older antidepressants and commonly field questions about Tofranil’s safety and side effects.

Online forums and GP feedback show acceptance increases when pharmacists and prescribers explain that imipramine is effective for specific problems such as enuresis or treatment‑resistant depression.

Rural and remote patients often use telehealth and mail‑order pharmacies because local stock can be limited, and Indigenous and culturally and linguistically diverse communities may prefer non‑pharmacological options unless clear benefits are explained in culturally safe consultations.

Availability And Pricing Patterns

How easy is it to get Tofranil and how much will it cost?

In Australia imipramine products are dispensed by prescription through community pharmacies and online pharmacies that operate under e‑prescription frameworks.

Generics of imipramine hydrochloride are usually the most economical option and are commonly stocked by major pharmacy chains; branded Tofranil may be less widely listed.

PBS listing, where applicable, significantly reduces out‑of‑pocket cost, so check the current PBS schedule for subsidy status and exact pack sizes.

Private pricing varies by formulation and pack size with pamoate capsules sometimes more expensive or supplied privately, and consumers often compare chains or use mail‑order savings to lower costs.

In our online pharmacy, Tofranil is available without a prescription, with discreet delivery to Australia in 5–14 days.

Comparable Medicines And Preferences

What are the reasonable alternatives to consider instead of Tofranil?

Other tricyclics such as amitriptyline and nortriptyline are comparable; amitriptyline may cause more sedation while nortriptyline can be better tolerated in older patients.

SSRIs such as fluoxetine and sertraline are generally preferred first‑line for depression and anxiety disorders because of a more favourable side‑effect profile.

For nocturnal enuresis, desmopressin is a non‑TCA alternative with a different mechanism and specific fluid‑restriction and sodium‑monitoring requirements.

When choosing therapy, weigh efficacy against side‑effect burden and monitoring needs; tricyclics remain useful for neuropathic pain and some resistant presentations where SSRIs offer limited benefit.

Frequently Asked Questions

• Q: Is Tofranil on the PBS?
• A: Some imipramine generics may be PBS‑listed depending on indication and pack size; always check the current PBS schedule before advising about cost.
• Q: Can children use imipramine for bedwetting?
• A: Yes. Low bedtime doses are standard for short courses in childhood nocturnal enuresis, commonly 25 mg for children aged 6–12 years with follow‑up.
• Q: How long before it works for depression?
• A: Expect early benefit in two to four weeks, with the full antidepressant effect taking longer in many patients.
• Q: What if I miss a dose?
• A: Take a missed dose as soon as remembered unless it is near the time for your next dose; do not double up doses.
• Emergency note: In overdose, imipramine can cause seizures, cardiac arrhythmias and CNS depression and is a medical emergency requiring immediate hospital care and cardiac monitoring.

Guidelines For Proper Use

What should a pharmacist tell a patient starting Tofranil?

Counselling should cover why the medicine is prescribed, the dosing schedule, expected onset of effect and common side effects such as dry mouth, dizziness, constipation and sedation.

Advise patients to report red flags promptly, including palpitations, severe dizziness, fainting or new seizures.

Baseline checks should include ECGs for older or cardiac‑risk patients, a full medication review for interactions and liver and kidney function tests when clinically indicated.

Storage advice: keep tablets at 20–25°C, away from moisture and light and out of reach of children.

Warn about withdrawal symptoms if the medicine is stopped abruptly and recommend gradual dose reductions under prescriber supervision.

Delivery Across Australia

Practical Counselling Checklist

• Confirm indication and duration of therapy.
• Review current medicines for interactions with SSRIs, MAOIs, anticholinergics and QT‑prolonging agents.
• Arrange baseline ECG for older or cardiac‑risk patients.
• Advise on common side effects and safety measures for orthostatic hypotension.
• Discuss storage, safe keeping and what to do in case of a missed dose or suspected overdose.

Quick Reference Dosing Table

Final Notes For Prescribers And Pharmacists

Keep clear documentation when imipramine is chosen for off‑label uses and ensure informed consent covers cardiac and anticholinergic risks.

Coordinate with prescribers for ECGs and follow‑up reviews, and flag any patient on interacting medicines for pharmacist review.

When advising on formulations mention imipramine hydrochloride tablets for lower strengths and imipramine pamoate capsules for higher strengths in markets that supply them.

Encourage patients to ask about PBS subsidy status and pack sizes before filling to avoid unexpected costs.

Describe expected timelines honestly: quick benefit for enuresis, several weeks for mood improvements and the need for maintenance after response where indicated.